Article

Escalating Drug Costs Highlight AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top stories of the week from The American Journal of Pharmacy Benefits.

Related Videos
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Microscopic View of Hematological Slide Showing Thrombocytopenia and Low Platelet Count in Blood
May 31st 2025

IVIG Increases Platelet Counts in Pregnant Patients With Severe Thrombocytopenia, With Identifiable Aspects of Response

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Image depicting kidney affected by CKD -- Image credit: Crystal light | stock.adobe.com
May 30th 2025

Cellular Senescence is a Central Driver of Chronic Kidney Disease-Related Kidney Fibrosis

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Model of a kidney depicting CKD -- Image credit: kanruthai | stock.adobe.com
May 29th 2025

Childhood Cancer Survivors at an Increased Risk of Developing CKD, Study Finds

Gillian McGovern, Associate Editor
Prague, Czech Republic - August 28 2024: STELARA box with USTEKINUMAB active substance by JANSSEN, used for psoriasis, Crohn’s disease, and ulcerative colitis.
May 28th 2025

FDA Approves Ustekinumab-hmny Injection, a Biosimilar Referencing Stelara

Luke Halpern, Assistant Editor